Search Results - "BABAR, LAILA"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    Retrospective analysis of outcomes with different adjuvant treatments in cholangiocarcinoma: An NCDB review by Mamadgi, Jyothika, Babar, Laila, Lundeen, Kristina, Abel, Stephen, Verma, Vivek, Wegner, Rodney E, Raj, Moses S.

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only e15677 Background: Annually approximately 5000 cases of cholangiocarcinoma are reported in the US. Of these, less than 40% are treated surgically…”
    Get full text
    Journal Article
  7. 7

    Evaluation of readmission rates for gastrointestinal bleeds in high risk oncologic patients by Babar, Laila, Bakalov, Veli, Monga, Dulabh K., Chahine, Zena, Ashraf, Obaid

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only e23031 Background: Gastrointestinal bleeding (GIB) results in high rates of hospital admissions, readmissions, significant morbidity and high…”
    Get full text
    Journal Article
  8. 8

    Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma by Babar, Laila, Zaidi, Ali Hussainy, Omstead, Ashten N., Zheng, Ping, Kelly, Ronan Joseph, Jobe, Blair Anderson

    Published in Journal of clinical oncology (01-02-2019)
    “…Abstract only 50 Background: Treatment options and risk stratification for esophageal adenocarcinomas (EAC) primarily rely on clinical and pathological…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11

    A retrospective analysis of factors affecting palliative care consult in patients undergoing cytoreductive surgery and HIPEC by Babar, Laila, Lo, Herman, Ashraf, Obaid, Sethi, Ashish, Alvi, Zara, Finley, Gene Grant, Monga, Dulabh K., Schiffman, Suzanne, Raj, Moses S.

    Published in Journal of clinical oncology (01-02-2020)
    “…Abstract only 815 Background: The National Cancer Institute defines palliative care as care given to improve the quality of life (QOL) for patients with life…”
    Get full text
    Journal Article
  12. 12

    Risk factors for opioid abuse/dependence in hospitalized cancer patients in the United States by Bakalov, Veli, Tang, Amy, Yellala, Amulya, Babar, Laila, Shah, Rupin, Sadashiv, Santhosh K., Kaplan, Robert B., Lister, John, Cuevas, Elizabeth, Monga, Dulabh K.

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only 11589 Background: Opioid medications are the mainstay for treating cancer pain. Goal of this study was to identify risk factors for opioid…”
    Get full text
    Journal Article
  13. 13

    The prognostic value of KRAS mutation in locally advanced rectal cancer by Bakalov, Veli, Hasan, Shaakir, Abel, Stephen, Babar, Laila, Shaikh, Hira, Raj, Moses S., Finley, Gene Grant, Monga, Dulabh K., Kirichenko, Alexander V., Wegner, Rodney E

    Published in Journal of clinical oncology (20-05-2019)
    “…Abstract only e15090 Background: The prognostic value and prognostic value of the KRAS proto-oncogene mutation in colorectal cancer has been debated. Herein,…”
    Get full text
    Journal Article
  14. 14

    Temporal trends and disease characteristics associated with total neoadjuvant therapy (TNT) usage by Babar, Laila, Bakalov, Veli, Abel, Stephen, Finley, Gene Grant, Raj, Moses S., Monga, Dulabh K., Kirichenko, Alexander V., Wegner, Rodney E

    Published in Journal of clinical oncology (01-02-2019)
    “…Abstract only 642 Background: Neoadjuvant chemoradiotherapy (nCRT) followed by resection and postoperative multi-agent chemotherapy (maChT) is the standard of…”
    Get full text
    Journal Article
  15. 15
  16. 16

    Intratumoral immunotherapy with STING agonist, ADU-S100, induces CD8+ T-cell mediated anti-tumor immunity in an esophageal adenocarcinoma model by Zaidi, Ali H, Kelly, Ronan J, Gorbunova, Anastasia, Omstead, Ashten N, Salvitti, Madison S, Zheng, Ping, Kosovec, Juliann E, Lee, Soyoung, Ayazi, Shahin, Babar, Laila, Finley, Gene G, Goel, Ajay, Jobe, Blair A

    Published in Oncotarget (16-02-2021)
    “…Esophageal adenocarcinoma (EAC) is a deadly disease with limited treatment options. STING is a transmembrane protein that activates transcription of interferon…”
    Get full text
    Journal Article
  17. 17

    Schnitzler’s Syndrome: A Diagnostic Consideration in Evaluating the Constellation of Monoclonal Gammopathy and Chronic Urticaria by Mamadgi, Jyothika, Babar, Laila, Bhagavatula, Rama, Sadashiv, Santhosh, Dantey, Kossivi, Apostolova, Mariya

    Published in Journal of hematology (01-06-2021)
    “…Schnitzler’s syndrome is a rare clinical entity characterized by intermittent, non-pruritic urticarial rash, fevers, arthralgias, myalgias and monoclonal…”
    Get full text
    Journal Article
  18. 18

    Prognostic immune markers for recurrence and survival in locally advanced esophageal adenocarcinoma by Babar, Laila, Kosovec, Juliann E, Jahangiri, Vida, Chowdhury, Nobel, Zheng, Ping, Omstead, Ashten N, Salvitti, Madison S, Smith, Matthew A, Goel, Ajay, Kelly, Ronan J, Jobe, Blair A, Zaidi, Ali H

    Published in Oncotarget (16-07-2019)
    “…Treatment options and risk stratification for esophageal adenocarcinomas (EAC) currently rely on pathological criteria such as tumor staging. However, with…”
    Get full text
    Journal Article
  19. 19
  20. 20

    A Retrospective Analysis of Factors Affecting Palliative Care Consults in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy by Rodriguez, Robin R, Babar, Laila, Lo, Herman, Ashraf, Obaid, Monga, Dulabh, Finley, Gene, Doverspike, Lisa, Blackledge, Amber, Sethi, Ashish, Raj, Moses S

    Published in Curēus (Palo Alto, CA) (09-01-2021)
    “…Purpose This study was conducted to determine factors that influence palliative care (PC) consultation in patients receiving cytoreductive surgery (CRS) with…”
    Get full text
    Journal Article